Photobiomodulation for Dry Age Related Macula Degeneration

Sponsor
Oslo University Hospital
Study ID
NCT05507840
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Valeda machine — DEVICE
    Photobiomodulation treatment with Valeda machine will be applied every six months for 2 years in patients with dry age related macula degeneration.

Study Details

The study will investigate the effect of photobiomodulation treatment on the risk of developing late age related macula degeneration (AMD) in the study eye in patients with wet AMD in the fellow eye.

Key Dates

First listed
Aug 19, 2022
Start date
Dec 1, 2022
Status verified
Oct 2022
Primary completion
Dec 1, 2026
Completion
Dec 1, 2027

Study Design

Enrollment
121 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention
    Near or infra red light provided by the Valeda machine will be applied in the intervention eye
  • Sham Comparator: Control
    Light with very low intensity provided by the same Valeda machine will be applied in the control eye

Primary Outcome Measure

Percentage of patients that develope late AMD in the study eye compared with control after 3 years of follow-up [ Time Frame: 3 years ]

Find similar trials

Nationwide
Age-related macular degeneration trialsOphthalmology trialsRetina trials

Related Studies